Literature DB >> 2953763

Different reactivity of monoclonal antibodies against common acute lymphoblastic leukaemia antigen (CD10).

S Haralambidou, J V Melo, D Catovsky.   

Abstract

The reactivity of five monoclonal antibodies J5, OKB-cALLA, Nu-N1, Nu-N2 and VIL-A1 against the common acute lymphoblastic leukaemia (common-ALL) antigen (glycoprotein 100, CD10); was investigated by indirect immunofluorescence in cell suspensions, and by immunoperoxidase in cytocentrifuge slides of ALL, chronic B cell lymphoproliferative disorders, and plasma cell dyscrasias. The five monoclonal antibodies gave similar positive results with both techniques only in samples of ALL. J5 was positive in variable degrees by immunofluorescence in the majority of B cell disorders examined but this was not confirmed by immunoperoxidase. OKB-cALLA reacted in a similar way to J5 in both techniques, although with a lower percentage of cells by immunofluorescence. Nu-N1, Nu-N2, and VIL-A1 were mainly negative when tested by both immunofluorescence and immunoperoxidase in B cell disorders other than ALL and therefore seemed to be more specific for the diagnosis of common-ALL.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2953763      PMCID: PMC1141009          DOI: 10.1136/jcp.40.5.490

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  12 in total

1.  Antisera to acute lymphoblastic leukemia cells.

Authors:  M F Greaves; G Brown; N T Rapson; T A Lister
Journal:  Clin Immunol Immunopathol       Date:  1975-05

2.  The biochemical characterization of a cell surface antigen associated with acute lymphoblastic leukemia and lymphocyte precursors.

Authors:  R A Newman; R Sutherland; M F Greaves
Journal:  J Immunol       Date:  1981-05       Impact factor: 5.422

3.  Antigenic and enzymatic phenotypes of the pre-B subclass of acute lymphoblastic leukaemia.

Authors:  M Greaves; W Verbi; L Vogler; M Cooper; R Ellis; K Ganeshaguru; V Hoffbrand; G Janossy; F J Bollum
Journal:  Leuk Res       Date:  1979       Impact factor: 3.156

4.  J-5 antibody and prolymphocytic leukemia.

Authors:  A Berrebi; M Talmor; N Galili
Journal:  Blood       Date:  1983-11       Impact factor: 22.113

5.  Monocyte markers and the common acute lymphoblastic leukemia antigen on chronic lymphocytic leukemia cells.

Authors:  F S Ligler; M L Schlam; R Curley; I Brodsky; J E Benzel
Journal:  Am J Hematol       Date:  1983-12       Impact factor: 10.047

Review 6.  The normal and malignant germinal centre.

Authors:  H Stein; J Gerdes; D Y Mason
Journal:  Clin Haematol       Date:  1982-10

7.  Expression of common acute lymphoblastic leukemia antigen (CALLA) by lymphomas of B-cell and T-cell lineage.

Authors:  J Ritz; L M Nadler; A K Bhan; J Notis-McConarty; J M Pesando; S F Schlossman
Journal:  Blood       Date:  1981-09       Impact factor: 22.113

8.  A monoclonal antibody to human acute lymphoblastic leukaemia antigen.

Authors:  J Ritz; J M Pesando; J Notis-McConarty; H Lazarus; S F Schlossman
Journal:  Nature       Date:  1980-02-07       Impact factor: 49.962

9.  VIL-A1, a monoclonal antibody reactive with common acute lymphatic leukemia cells.

Authors:  W Knapp; O Majdic; P Bettelheim; K Liszka
Journal:  Leuk Res       Date:  1982       Impact factor: 3.156

Review 10.  Selective expression of the common acute lymphoblastic leukemia (gp 100) antigen on immature lymphoid cells and their malignant counterparts.

Authors:  M F Greaves; G Hariri; R A Newman; D R Sutherland; M A Ritter; J Ritz
Journal:  Blood       Date:  1983-04       Impact factor: 22.113

View more
  1 in total

1.  CD10/neutral endopeptidase 24.11 in developing human fetal lung. Patterns of expression and modulation of peptide-mediated proliferation.

Authors:  M E Sunday; J Hua; J S Torday; B Reyes; M A Shipp
Journal:  J Clin Invest       Date:  1992-12       Impact factor: 14.808

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.